← USPTO Patent Applications

ABHD6 ANTAGONIST

Application US20260083735A1 Kind: A1 Mar 26, 2026

Assignee

ONO PHARMACEUTICAL CO., LTD.

Inventors

Atsushi YOSHIDA, Ryuichi HYAKUTAKE, Nozomu NAGASHIMA, Ryosuke MISU, Shohei MORI

Abstract

A drug is provided, which contains, as an active ingredient, a compound having ABHD6 inhibitory activity in prevention and/or treatment of a disease associated with ABHD6. A compound represented by general formula (I) or a pharmaceutically acceptable salt thereof has ABHD6 inhibitory activity and therefore is useful as a pharmaceutical ingredient having potent ABHD6 inhibitory activity in the prevention and/or treatment of a disease associated with ABHD6: in which all symbols represent the same meaning as the symbols described in the specification.

CPC Classifications

A61K 31/5025 A61K 31/167 A61K 31/501 A61K 45/06 A61P 25/22 A61P 25/24 A61P 29/00 C07D 409/14 C07D 417/14 C07D 495/04 C07D 513/04 C07D 519/00

Filing Date

2023-09-29

Application No.

19113663